Your browser doesn't support javascript.
loading
Real-world dosing of regorafenib and outcomes among patients with metastatic colorectal cancer: a retrospective analysis using US claims data.
Bekaii-Saab, Tanios; Khan, Nasreen; Ostojic, Helene; Jiao, XiaoLong; Chen, Guifang; Lin, Wenlong; Bruno, Amanda.
Afiliação
  • Bekaii-Saab T; Mayo Clinic, 5777 E. Mayo Blvd, Phoenix, AZ, 85054, USA. Bekaii-Saab.Tanios@Mayo.edu.
  • Khan N; Bayer HealthCare Pharmaceuticals, 100 Bayer Blvd, Whippany, NJ, 07981, USA.
  • Ostojic H; Bayer Consumer Care, Peter Merian-Strasse 84, Basel, 4052, Switzerland.
  • Jiao X; Bayer HealthCare Pharmaceuticals, 100 Bayer Blvd, Whippany, NJ, 07981, USA.
  • Chen G; Pfizer, 66 Hudson Blvd, New York, NY, USA.
  • Lin W; Bayer HealthCare Pharmaceuticals, 100 Bayer Blvd, Whippany, NJ, 07981, USA.
  • Bruno A; Bayer HealthCare Pharmaceuticals, 100 Bayer Blvd, Whippany, NJ, 07981, USA.
BMC Cancer ; 24(1): 939, 2024 Aug 02.
Article em En | MEDLINE | ID: mdl-39095766
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Piridinas / Neoplasias Colorretais Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Piridinas / Neoplasias Colorretais Idioma: En Ano de publicação: 2024 Tipo de documento: Article